Bausch Health Companies Inc.
At Close: 4:00 PM
BHC Stock Price Graph
BHC Stock Price Today
Bausch Health Companies Inc. (BHC) stock declined over -0.44% intraday to trade at $6.86 a share on NYSE. The stock opened with a loss of -2.90% at $6.69 and touched an intraday high of $6.70, falling -0.44% against the last close of $6.89. The Bausch Health Companies Inc. in stock market went to a low of $6.53 during the session.
BHC Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
BHC Stock Price History Chart
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Frequently Asked Questions
What is the current Bausch Health Companies Inc. (BHC) stock price?
Bausch Health Companies Inc. (NYSE: BHC) stock price is $6.86 in the last trading session. During the trading session, BHC stock reached the peak price of $6.70 while $6.53 was the lowest point it dropped to. The percentage change in BHC stock occurred in the recent session was -0.44% while the dollar amount for the price change in BHC stock was -$0.03.
BHC's industry and sector of operation?
The NYSE listed BHC is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Bausch Health Companies Inc. , together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.
Who are the executives of BHC?
Mr. Arthur J. Shannon
Senior Vice President and Head of Investor Relations & Global Communications
Mr. John S. Barresi
Senior Vice President, Controller & Chief Accounting Officer
Ms. Kathleen Fitzpatrick
Senior Vice President & Chief HR Officer
Ms. Seana Carson
Executive Vice President & Gen. Counsel
How BHC did perform over past 52-week?
BHC's closing price is 0.48% higher than its 52-week low of $5.57 where as its distance from 52-week high of $10.23 is -0.68%.
How many employees does BHC have?
Number of BHC employees currently stands at N/A. BHC operates from 2150 St. ElzEar Boulevard West, Laval, QC H7L 4A8, CA.
Link for BHC official website?
Official Website of BHC is: https://www.bauschhealth.com
How do I contact BHC?
How many shares of BHC are traded daily?
BHC stock volume for the day was 1026378.00 shares. The average number of BHC shares traded daily for last 3 months was 2.84 Million.
What is the market cap of BHC currently?
The market value of BHC currently stands at $2.51 Billion with its latest stock price at $6.86 and N/A of its shares outstanding.